Table of Contents
PPT Slide
PPT Slide
PPT Slide
PPT Slide
Well Established Technology Platform
Leadership in Oral Drug Delivery: Differentiation
PROTECT Phase III Overview
PROTECT Confirms Viable Oral Drug Delivery Technology
PROTECT Results
PROTECT Takeaways
Emisphere Post-PROTECT
PPT Slide
Heparin Solid Dosage: Development Status and Positioning
PPT Slide
Oral Insulin
Insulin: Oral Delivery
Emisphere’s Oral Insulin Candidate
PPT Slide
Insulin Partnership Update: Development
Insulin Partnership Update: Discussions
Oral Cromolyn Sodium
Clinical Data Summary: Multi-dose Study
2002 Program Initiatives/Milestones
2002 Program Initiatives/Milestones
Integrated Product Development
Our Business Strategy into 2003: Product Development
Business Strategy into 2003: Strategic Planning
Current Cash and Assets
The Emisphere Advantage Investment Thesis
PPT Slide
|
Author: Shepard M. Goldberg
|